联环药业：预计2025年净利润为负

Core Viewpoint - The company, Lianhuan Pharmaceutical, has announced that it expects a negative net profit attributable to shareholders for the fiscal year 2025, indicating an anticipated operational loss for that year [1] Financial Performance - The preliminary assessment by the financial department suggests that the company's operating performance will decline significantly in 2025, leading to a projected loss [1]